Volta

Diagnostic accuracy of thirteen COVID‐19 (SARS‐CoV‐2) rapid antigen self‐tests with very high sensitivity approved for home use in Australia

Unknown authors · 2022
hash_id: 4d72286df0f9624d3de820153536e3872380c7596b7e91cd4fc2bbcbe08ddaa7 · DOI: 10.1111/1753-6405.13285

Reference & gravity metrics

Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP

Secondary-market trade history

No secondary-market trades recorded for this Volta yet.

References (0)

No outbound references recorded.

Cited by (1)

Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An up… secondary